Cash prices

  • 文章类型: Journal Article
    背景:社会风险因素是美国支出地域差异的主要驱动因素,但鲜为人知的是社区层面的社会风险因素与医院价格的关系。我们的目标是按价格类型描述区域医院报告价格与社会风险因素之间的关系(chargemaster,cash,商业,Medicare,和医疗补助)。
    方法:本横断面分析使用了2022年急诊综合医院最新提供的医院报告价格。价格为14项共同服务。价格为98%,工资指数调整后,按服务标准化,并汇总到医院服务区(HSA)。对于社会风险,我们在5个社会风险领域(社会经济地位;种族,种族,和文化;性别;社会关系;以及住宅和社区环境)。Spearman的相关性用于估计价格类型的中位数价格和社会风险之间的关联。
    结果:报告了2,386家急性综合医院的价格,占45%(3,436个中的1,502个)HSA。区域价格与其他社会风险因素之间的相关性因价格类型而异(范围:-0.19至0.31)。Chargemaster和现金价格与大多数社区特征(23中的10,43%)显着相关,其次是商业价格(8,35%)。医疗保险和医疗补助价格仅与1项指标显着相关(所有p<0.01)。所有价格类型均与未投保百分比显着相关(均p<0.01)。主管,cash,商业价格与西班牙裔居民的百分比呈正相关,英语水平有限的居民,和非公民(所有p<0.05)。
    结论:虽然价格和社会风险因素之间的区域相关性在所有价格中都很弱,chargemaster,cash,与两个公共付款人(Medicare和Medicaid)相比,商业价格更像是与社区层面的社会风险因素密切相关。主管,cash,在社会弱势社区,商业医院的价格似乎更高。需要进一步研究以阐明价格与社区社会风险因素之间的关系。
    BACKGROUND: Social risk factors are key drivers of the geographic variation in spending in the United States but little is known how community-level social risk factors are associated with hospital prices. Our objective was to describe the relationship between regional hospital-reported prices and social risk factors by price type (chargemaster, cash, commercial, Medicare, and Medicaid).
    METHODS: This cross-sectional analysis used newly available hospital-reported prices from acute general hospitals in 2022. The prices were for 14 common services. Prices were winsorized at 98%, wage index-adjusted, standardized by service, and aggregated to hospital service areas (HSAs). For social risk, we used 23 measures across 5 domains of social risk (socioeconomic position; race, ethnicity, and culture; gender; social relationships; and residential and community context). Spearman\'s correlation was used to estimate associations between median prices and social risk by price type.
    RESULTS: Prices were reported from 2,386 acute general hospitals in 45% (1,502 of 3,436) HSAs. Correlations between regional prices and other social risk factors varied by price type (range: -0.19 to 0.31). Chargemaster and cash prices were significantly correlated with the most community characteristics (10 of 23, 43%) followed by commercial prices (8, 35%). Medicare and Medicaid prices were only significantly correlated with 1 measure (all p < 0.01). All price types were significantly correlated with the percentage of uninsured (all p < 0.01). Chargemaster, cash, and commercial prices were positively correlated with percentage of Hispanic residents, residents with limited English proficiency, and non-citizens (all p < 0.05).
    CONCLUSIONS: While regional correlations between prices and social risk factors were weak across all prices, chargemaster, cash, and commercial prices were more like closely aligned with community-level social risk factors than the two public payers (Medicare and Medicaid). Chargemaster, cash, and commercial hospital prices appeared to be higher in socially disadvantaged communities. Further research is needed to clarify the relationship between prices and community social risk factors.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    In addition to the prices they negotiate with private health insurers, most providers also have a cash price schedule for patients who have the wherewithal to ask and are willing to pay in full when they receive a service. This is the first study that estimates the potential cost saving of allowing privately-insured consumers to observe both in-network negotiated prices and cash prices, which is of particular interest given the growing importance of high-deductible health plans and a recent executive order mandating greater price transparency. Using data from five private health insurers and 142 imaging facilities in the San Francisco Bay Area, we estimate that patients could save between 10% and 22% of their insurer\'s in-network price by paying cash. Potential savings are much larger (between 45% and 64% of their insurer\'s in-network price) if consumers observe both cash and in-network prices and select the facility in the region offering the lowest price for a particular service.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    Cash prices for prescription drugs vary among community pharmacies in the USA. GoodRx is a discount platform that provides coupons for use in community pharmacies without a membership requirement. Analytical pharmacy is a new type of pharmacy that tests drugs before dispensing to verify medication quality.
    To compare undiscounted and GoodRx-discounted cash prices for common cardiovascular (CV) drugs by pharmacy type.
    A cross-sectional study.
    GoodRx-discounted and GoodRx-undiscounted cash price data; analytical pharmacy cash price data (all data collected in July 2020).
    GoodRx cash price data for 30 units of 41 generic and 16 brand-name common cardiovascular medications at mass merchandiser, regional supermarket, two national chains, and analytical pharmacy (only one of its kind in the USA).
    The average (SD) undiscounted generic CV medication cash price was $42.41 (44.1). The average GoodRx-discounted generic CV medication cash prices were $11.01 (8.6), $9.88 (6.7), $17.85 (10.5), and $21.73 (14.1) in mass merchandiser, supermarket, and two national chain pharmacies, respectively. The average generic CV medication cash price was $20.84 (25.7) at the analytical pharmacy. The average (SD) undiscounted brand-name CV medication cash price was $368.33 (127.00). The average GoodRx-discounted brand-name CV medication cash prices were $269.16 (118.1), $258.84 (108.6), $270.28 (118.4), and $274.60 (122.50) for mass merchandiser, supermarket, and two national chain pharmacies, respectively. The average (SD) brand-name CV medication cash price was $365.12 (116.20) at the analytical pharmacy.
    GoodRx-discounted cash prices of generic CV medications were significantly lower than undiscounted cash prices at supermarket, mass merchandiser, and national chain pharmacies. Analytical pharmacy cash prices too were significantly lower than traditional pharmacy undiscounted cash prices. GoodRx-discounted prices for brand-name CV medications did not differ significantly from undiscounted cash prices and between pharmacy types.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号